PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34672772-5	2021	To investigate the underlying mechanisms through which DAP reduces urinary albumin excretion, we used RNA-sequencing (RNA-seq) to analyze gene expression in human kidney 2 (HK-2) cells treated with DAP.	dapagliflozin	198-201	hexokinase 2	Homo sapiens	173-177	
33048256-3	2021	We hypothesized that SGLT2 inhibitors Canagliflozin (Cana), Empagliflozin (Empa) or Dapagliflozin (Dapa) reduces inflammation via HKII in endothelial cells, and that HKII-dependent inflammation is determined by ERK1/2, NF-kappaB.	dapagliflozin	84-97	hexokinase 2	Homo sapiens	130-134	
33048256-3	2021	We hypothesized that SGLT2 inhibitors Canagliflozin (Cana), Empagliflozin (Empa) or Dapagliflozin (Dapa) reduces inflammation via HKII in endothelial cells, and that HKII-dependent inflammation is determined by ERK1/2, NF-kappaB.	dapagliflozin	84-97	hexokinase 2	Homo sapiens	166-170	
33048256-3	2021	We hypothesized that SGLT2 inhibitors Canagliflozin (Cana), Empagliflozin (Empa) or Dapagliflozin (Dapa) reduces inflammation via HKII in endothelial cells, and that HKII-dependent inflammation is determined by ERK1/2, NF-kappaB.	dapagliflozin	84-88	hexokinase 2	Homo sapiens	130-134	
33048256-3	2021	We hypothesized that SGLT2 inhibitors Canagliflozin (Cana), Empagliflozin (Empa) or Dapagliflozin (Dapa) reduces inflammation via HKII in endothelial cells, and that HKII-dependent inflammation is determined by ERK1/2, NF-kappaB.	dapagliflozin	84-88	hexokinase 2	Homo sapiens	166-170	
30387082-6	2019	By optimizing the passages of HK-2 cells, 2-NBDG concentration and incubation time, and by measuring glucose uptake treated by Dapagliflozin, a clinical drug of SGLT2 inhibitors, we successfully developed a new assay for measuring glucose uptake through SGLT2.	dapagliflozin	127-140	hexokinase 2	Homo sapiens	30-34	
34672772-7	2021	The results of the RNA-seq experiments showed 349 differentially expressed genes between DAP-treated HK-2 cells and control cells.	dapagliflozin	89-92	hexokinase 2	Homo sapiens	101-105